Targeted protein modulation
guided by disease biology
Tamino Bio is a biotechnology platform company focused on disease-relevant protein regulation, targeted protein modulation, and translational therapeutic validation.
Translating protein regulation into therapeutic strategy
Tamino Bio integrates post-translational modification biology, targeted protein modulation, multi-omic biomarkers, and translational validation to identify biological control points that translate molecular mechanisms into therapeutic strategy.
A scalable discovery platform
Our platform integrates disease biology, protein regulation, multi-omics, and translational validation to identify therapeutic opportunities across multiple diseases and biological pathways.
Disease Biology
Identifying biological control points where altered protein regulation contributes to disease mechanisms.
Targeted Protein Modulation
Developing strategies to selectively alter the activity, stability, localization, or function of disease-associated proteins.
Translational Validation
Testing prioritized mechanisms in disease-focused models, cellular systems, and human molecular datasets.
Science Pillars
Our platform integrates PTM biology, molecular profiling, disease biology, and therapeutic strategy to guide targeted protein modulation.
Post-Translational Modification Biology
Understanding how protein modifications influence signaling, cellular state, and disease progression.
Multi-Omic Biomarkers
Integrating proteomic, phosphoproteomic, transcriptomic, and other molecular readouts to measure biology and guide development.
Disease-Focused Models
Using translational models to test biological mechanisms in disease contexts.
Therapeutic Strategy
Advancing targeted modulation strategies guided by disease biology and molecular evidence.
Initial Scientific Programs
Tamino Bio’s initial programs apply PTM biology, multi-omic biomarkers, and disease-focused validation to identify biological control points for therapeutic modulation.
Initial Scientific Focus
Tamino Bio’s initial work is grounded in post-translational modification biology, including O-GlcNAc-mediated protein regulation, with kidney disease serving as the initial therapeutic indication for platform development.
Protein Regulation as Therapeutic Strategy
Protein regulation provides a framework for identifying biological control points that can be therapeutically modulated to alter disease mechanisms.
Multi-Omics for Therapeutic Discovery
Multi-omic profiling helps connect molecular changes to disease biology, enabling mechanism-guided prioritization of therapeutic strategies.
Our Approach
Tamino Bio connects molecular mechanism, multi-omic evidence, and translational validation to prioritize protein regulation strategies.
Define Disease Biology
Use molecular profiling, disease biology, and multi-omic data to identify biological control points for therapeutic intervention.
Prioritize Modulation Strategies
Evaluate therapeutic approaches that can restore, redirect, or selectively alter disease-associated protein function.
Validate Translational Biology
Test prioritized mechanisms in disease models, cellular systems, and human molecular datasets.